{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["apoptosis", "leukemia cells", "quinazoline\u2013sulfonamide", "zebrafish"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35563111", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "17"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "25"}], "Language": ["eng"], "ELocationID": ["4720", "10.3390/ijms23094720"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "25"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Cytotoxicity of Newly Synthesized Quinazoline-Sulfonamide Derivatives in Human Leukemia Cell Lines and Their Effect on Hematopoiesis in Zebrafish Embryos.", "Abstract": {"AbstractText": ["Many quinazoline derivatives with pharmacological properties, such as anticancer activity, have been synthesized. Fourteen quinazoline derivatives bearing a substituted sulfonamide moiety (<b>4a-n</b>) were previously synthesized and fully characterized. These compounds exerted antiproliferative activity against cell lines derived from solid tumors. Herein, the antileukemic activities of these compounds (<b>4a-n</b>) against two different leukemia cell lines (Jurkat acute T cell and THP-1 acute monocytic) were investigated. Our investigation included examining their activity in vivo in a zebrafish embryo model. Remarkably, compounds <b>4a</b> and <b>4d</b> were the most potent in suppressing cell proliferation, with an IC<sub>50</sub> value range of 4-6.5 \u00b5M. Flow cytometry analysis indicated that both compounds halted cell progression at the G2/M phase and induced apoptosis in a dose-dependent manner. RT-PCR and Western blot analyses also showed that both compounds effectively induced apoptosis by upregulating the expression of proapoptotic factors while downregulating that of antiapoptotic factors. In vivo animal toxicity assays performed in zebrafish embryos indicated that compound <b>4d</b> was more toxic than compound <b>4a</b>, with compound <b>4d</b> inducing multiple levels of teratogenic phenotypes in zebrafish embryos at a sublethal concentration. Moreover, both compounds perturbed the hematopoiesis process in developing zebrafish embryos. Collectively, our data suggest that compounds <b>4a</b> and <b>4d</b> have the potential to be used as antileukemic agents."]}, "AuthorList": [{"Identifier": ["0000-0002-1034-7441"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia."}], "LastName": "Alqahtani", "ForeName": "Ali S", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Nasr City, Cairo 11371, Egypt."}], "LastName": "Ghorab", "ForeName": "Mostafa M", "Initials": "MM"}, {"Identifier": ["0000-0002-6496-7822"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia."}], "LastName": "Nasr", "ForeName": "Fahd A", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia."}], "LastName": "Ahmed", "ForeName": "Mohammad Z", "Initials": "MZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia."}], "LastName": "Al Mishari", "ForeName": "Abdullah A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia."}], "LastName": "Attia", "ForeName": "Sabry M", "Initials": "SM"}, {"Identifier": ["0000-0001-9891-2443"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioproducts Research Chair, Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia."}], "LastName": "Farooq Khan", "ForeName": "Muhammad", "Initials": "M"}], "GrantList": [{"GrantID": "13-MED 997-02", "Agency": "King Abdulaziz City for Science and Technology", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinazolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfonamides"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Hematopoiesis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Leukemia"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Quinazolines"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sulfonamides"}, {"QualifierName": [], "DescriptorName": "Zebrafish"}], "CoiStatement": "The authors declare that they have no competing interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Nemkov T., D\u2019Alessandro A., Reisz J.A. Metabolic underpinnings of leukemia pathology and treatment. Cancer Rep. 2019;2:e1139. doi: 10.1002/cnr2.1139.", "ArticleIdList": ["10.1002/cnr2.1139", "PMC7941580", "32721091"]}, {"Citation": "Wendtner C.M., Gregor M. Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia. Leuk. Lymphoma. 2018;59:300\u2013310. doi: 10.1080/10428194.2017.1330474.", "ArticleIdList": ["10.1080/10428194.2017.1330474", "28565930"]}, {"Citation": "Maher T., Ahmad Raus R., Daddiouaissa D., Ahmad F., Adzhar N.S., Latif E.S., Abdulhafiz F., Mohammed A. Medicinal Plants with Anti-Leukemic Effects: A Review. Molecules. 2021;26:2741. doi: 10.3390/molecules26092741.", "ArticleIdList": ["10.3390/molecules26092741", "PMC8124366", "34066963"]}, {"Citation": "Alagarsamy V., Chitra K., Saravanan G., Solomon V.R., Sulthana M.T., Narendhar B. An overview of quinazolines: Pharmacological significance and recent developments. Eur. J. Med. Chem. 2018;151:628\u2013685. doi: 10.1016/j.ejmech.2018.03.076.", "ArticleIdList": ["10.1016/j.ejmech.2018.03.076", "29656203"]}, {"Citation": "Poudapally S., Battu S., Velatooru L.R., Bethu M.S., Janapala V.R., Sharma S., Sen S., Pottabathini N., Iska V.B.R., Katangoor V. Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents. Bioorg. Med. Chem. Lett. 2017;27:1923\u20131928. doi: 10.1016/j.bmcl.2017.03.042.", "ArticleIdList": ["10.1016/j.bmcl.2017.03.042", "28351589"]}, {"Citation": "Zhang B., Liu Z., Xia S., Liu Q., Gou S. Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors. Eur. J. Med. Chem. 2021;216:113300. doi: 10.1016/j.ejmech.2021.113300.", "ArticleIdList": ["10.1016/j.ejmech.2021.113300", "33640672"]}, {"Citation": "Bhatia P., Sharma V., Alam O., Manaithiya A., Alam P., Kahksha J., Alam M.T., Imran M. Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015\u20132019) Eur. J. Med. Chem. 2020;204:112640. doi: 10.1016/j.ejmech.2020.112640.", "ArticleIdList": ["10.1016/j.ejmech.2020.112640", "32739648"]}, {"Citation": "Bansal R., Malhotra A. Therapeutic progression of quinazolines as targeted chemotherapeutic agents. Eur. J. Med. Chem. 2021;211:113016. doi: 10.1016/j.ejmech.2020.113016.", "ArticleIdList": ["10.1016/j.ejmech.2020.113016", "33243532"]}, {"Citation": "Mehndiratta S., Sapra S., Singh G., Singh M., Nepali K. Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature. Recent. Pat. Anticancer Drug Discov. 2016;11:2\u201366. doi: 10.2174/1574892811666151218151506.", "ArticleIdList": ["10.2174/1574892811666151218151506", "26681186"]}, {"Citation": "Alqahtani A.S., Ghorab M.M., Nasr F.A., Ahmed M.Z., Al-Mishari A.A., Attia S.M. The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study. Molecules. 2022;27:981. doi: 10.3390/molecules27030981.", "ArticleIdList": ["10.3390/molecules27030981", "PMC8838787", "35164248"]}, {"Citation": "de Pater E., Trompouki E. Bloody Zebrafish: Novel Methods in Normal and Malignant Hematopoiesis. Front. Cell Dev. Biol. 2018;6:124. doi: 10.3389/fcell.2018.00124.", "ArticleIdList": ["10.3389/fcell.2018.00124", "PMC6196227", "30374440"]}, {"Citation": "Huang Y., Yu S.H., Zhen W.X., Cheng T., Wang D., Lin J.B., Wu Y.H., Wang Y.F., Chen Y., Shu L.P., et al. Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2. Theranostics. 2021;11:6891\u20136904. doi: 10.7150/thno.53170.", "ArticleIdList": ["10.7150/thno.53170", "PMC8171091", "34093860"]}, {"Citation": "Jing L., Zon L.I. Zebrafish as a model for normal and malignant hematopoiesis. Dis. Model. Mech. 2011;4:433\u2013438. doi: 10.1242/dmm.006791.", "ArticleIdList": ["10.1242/dmm.006791", "PMC3124047", "21708900"]}, {"Citation": "Shapiro G.I., Harper J.W. Anticancer drug targets: Cell cycle and checkpoint control. J. Clin. Investig. 1999;104:1645\u20131653. doi: 10.1172/JCI9054.", "ArticleIdList": ["10.1172/JCI9054", "PMC409893", "10606615"]}, {"Citation": "Zury\u0144 A., Litwiniec A., Gackowska L., Pawlik A., Grzanka A.A., Grzanka A. Expression of cyclin A, B1 and D1 after induction of cell cycle arrest in the Jurkat cell line exposed to doxorubicin. Cell Biol. Int. 2012;36:1129\u20131135. doi: 10.1042/CBI20120274.", "ArticleIdList": ["10.1042/CBI20120274", "22950819"]}, {"Citation": "Mendivil-Perez M., Velez-Pardo C., Jimenez-Del-Rio M. Doxorubicin induces apoptosis in Jurkat cells by mitochondria-dependent and mitochondria-independent mechanisms under normoxic and hypoxic conditions. Anticancer Drugs. 2015;26:583\u2013598. doi: 10.1097/CAD.0000000000000223.", "ArticleIdList": ["10.1097/CAD.0000000000000223", "25734830"]}, {"Citation": "Ghasemi H., Jamshidi A., Ghatee M.A., Mazhab-Jafari K., Khorasani M., Rahmati M., Mohammadi S. PPAR\u03b3 activation by pioglitazone enhances the anti-proliferative effects of doxorubicin on pro-monocytic THP-1 leukemia cells via inducing apoptosis and G2/M cell cycle arrest. J. Recept. Signal. Transduct. Res. 2021;13:1\u201310. doi: 10.1080/10799893.2021.1988972.", "ArticleIdList": ["10.1080/10799893.2021.1988972", "34645362"]}, {"Citation": "Pistritto G., Trisciuoglio D., Ceci C., Garufi A., D\u2019Orazi G. Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8:603\u2013619. doi: 10.18632/aging.100934.", "ArticleIdList": ["10.18632/aging.100934", "PMC4925817", "27019364"]}, {"Citation": "Pfeffer C.M., Singh A.T.K. Apoptosis: A Target for Anticancer Therapy. Int. J. Mol. Sci. 2018;19:448. doi: 10.3390/ijms19020448.", "ArticleIdList": ["10.3390/ijms19020448", "PMC5855670", "29393886"]}, {"Citation": "Shagufta, Ahmad I. An insight into the therapeutic potential of quinazoline derivatives as anticancer agents. Medchemcomm. 2017;8:871\u2013885. doi: 10.1039/C7MD00097A.", "ArticleIdList": ["10.1039/C7MD00097A", "PMC6072504", "30108803"]}, {"Citation": "Campbell K.J., Tait S.W.G. Targeting BCL-2 regulated apoptosis in cancer. Open Biol. 2018;8:180002. doi: 10.1098/rsob.180002.", "ArticleIdList": ["10.1098/rsob.180002", "PMC5990650", "29769323"]}, {"Citation": "Walsh J.G., Cullen S.P., Sheridan C., L\u00fcthi A.U., Gerner C., Martin S.J. Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc. Natl. Acad. Sci. USA. 2008;105:12815\u201312819. doi: 10.1073/pnas.0707715105.", "ArticleIdList": ["10.1073/pnas.0707715105", "PMC2529079", "18723680"]}, {"Citation": "Bowman T.V., Zon L.I. Swimming into the future of drug discovery: In vivo chemical screens in zebrafish. ACS Chem. Biol. 2010;5:159\u2013161. doi: 10.1021/cb100029t.", "ArticleIdList": ["10.1021/cb100029t", "PMC4712380", "20166761"]}, {"Citation": "Chen A.T., Zon L.I. Zebrafish blood stem cells. J. Cell Biochem. 2009;108:35\u201342. doi: 10.1002/jcb.22251.", "ArticleIdList": ["10.1002/jcb.22251", "19565566"]}, {"Citation": "Rasighaemi P., Basheer F., Liongue C., Ward A.C. Zebrafish as a model for leukemia and other hematopoietic disorders. J. Hematol. Oncol. 2015;8:29. doi: 10.1186/s13045-015-0126-4.", "ArticleIdList": ["10.1186/s13045-015-0126-4", "PMC4389495", "25884214"]}, {"Citation": "Molina B., Chavez J., Grainger S. Zebrafish models of acute leukemias: Current models and future directions. Wiley Interdiscip. Rev. Dev. Biol. 2021;10:e400. doi: 10.1002/wdev.400.", "ArticleIdList": ["10.1002/wdev.400", "PMC8213871", "33340278"]}, {"Citation": "Mizgirev I.V., Revskoy S. A new zebrafish model for experimental leukemia therapy. Cancer Biol. Ther. 2010;9:895\u2013902. doi: 10.4161/cbt.9.11.11667.", "ArticleIdList": ["10.4161/cbt.9.11.11667", "20339318"]}, {"Citation": "Ridges S., Heaton W.L., Joshi D., Choi H., Eiring A., Batchelor L., Choudhry P., Manos E.J., Sofla H., Sanati A. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood J. Am. Soc. Hematol. 2012;119:5621\u20135631. doi: 10.1182/blood-2011-12-398818.", "ArticleIdList": ["10.1182/blood-2011-12-398818", "PMC3382926", "22490804"]}, {"Citation": "Gutierrez A., Pan L., Groen R.W., Baleydier F., Kentsis A., Marineau J., Grebliunaite R., Kozakewich E., Reed C., Pflumio F. Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia. J. Clin. Investig. 2014;124:644\u2013655. doi: 10.1172/JCI65093.", "ArticleIdList": ["10.1172/JCI65093", "PMC3904599", "24401270"]}, {"Citation": "Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., Schilling T.F. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995;203:253\u2013310. doi: 10.1002/aja.1002030302.", "ArticleIdList": ["10.1002/aja.1002030302", "8589427"]}, {"Citation": "Xiong J.W. Molecular and developmental biology of the hemangioblast. Dev. Dyn. 2008;237:1218\u20131231. doi: 10.1002/dvdy.21542.", "ArticleIdList": ["10.1002/dvdy.21542", "PMC3085530", "18429046"]}, {"Citation": "Ahmed M.Z., Nasr F.A., Qamar W., Noman O.M., Khan J.M., Al-Mishari A.A., Alqahtani A.S. Janerin Induces Cell Cycle Arrest at the G2/M Phase and Promotes Apoptosis Involving the MAPK Pathway in THP-1, Leukemic Cell Line. Molecules. 2021;26:7555. doi: 10.3390/molecules26247555.", "ArticleIdList": ["10.3390/molecules26247555", "PMC8705386", "34946628"]}, {"Citation": "Isogai S., Horiguchi M., Weinstein B.M. The vascular anatomy of the developing zebrafish: An atlas of embryonic and early larval development. Dev. Biol. 2001;230:278\u2013301. doi: 10.1006/dbio.2000.9995.", "ArticleIdList": ["10.1006/dbio.2000.9995", "11161578"]}, {"Citation": "Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio Rerio) University of Oregon Press; Eugene, OR, USA: 2000."}, {"Citation": "Schoofs G.M., Willhite C.C. A probit analysis program for the personal computer. J. Appl. Toxicol. 1984;4:141\u2013144. doi: 10.1002/jat.2550040305.", "ArticleIdList": ["10.1002/jat.2550040305", "6547736"]}, {"Citation": "Strahle U., Scholz S., Geisler R., Greiner P., Hollert H., Rastegar S., Schumacher A., Selderslaghs I., Weiss C., Witters H., et al. Zebrafish embryos as an alternative to animal experiments\u2014A commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod. Toxicol. 2012;33:128\u2013132. doi: 10.1016/j.reprotox.2011.06.121.", "ArticleIdList": ["10.1016/j.reprotox.2011.06.121", "21726626"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "28"}, {"Year": "2022", "Month": "4", "Day": "20"}, {"Year": "2022", "Month": "4", "Day": "22"}, {"Year": "2022", "Month": "5", "Day": "14", "Hour": "1", "Minute": "3"}, {"Year": "2022", "Month": "5", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["35563111", "PMC9104550", "10.3390/ijms23094720", "ijms23094720"]}}], "PubmedBookArticle": []}